$SLS +1. everyone should check $TERN fabulous 2,600% ride from $2 to $53 just in 1 year! TERN is very relevant, as it's for CML and got acquired for $6.7B with early stage data. BO premium was almost absent telling everyone that it's NOT WISE to get late on-board, if you look for big reward at BO. Some of my calls, for example, are > 10x just within a few months!
Check the historical $TERN price here -- on 4/8/2025 price was $2.05, and on 3/30/2026 price was $52.88! $SLS to meet & possibly beat it with blowout GPS readout!
https://www.macrotrends.net/stocks/charts/TERN/terns-pharmaceuticals/stock-price-history
$CRMD Quick look over at the gainers for today and I saw this grouping. How many Buyouts or deals did we have in this group? Good lord. Will $CRMD be added to that distinguished list? I think so.
For fun, the 2 picks above the screen grab was $AKRO, one below was $NUVL. $TERN? $VRNA? Some real life changes in here.
Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn.
Let's make some (more) money. Cheers!
$SLS blah blah blah.
Bears came out agains $CAPR at $7.X
Came out against $REPL at $3.X
Came out agains $TERN at $7.X
The science will dictate where we go with $SLS. The harder they short the bigger the potential to launch 10-20x
@PaulNipkow Very true, and I like it being your #1. It's up there on my Big Board as well. And $TERN was a beautiful turnaround and blockbuster. Truly an experience that helped continue to mold my investment strategies and news digestion.
Cheers!
$SLS they want the retail to sell. They dropped prices for multiple recent biotechs right before the rip.
$TERN
$CAPR
$ALMS
Hold the line or regret being Mcpaperhands.
Eli Lilly’s one-time gene editing therapy cut LDL cholesterol by 62% in Phase 1 trial participants, with effects lasting up to 18 months. No serious adverse events reported.
$LLY $NVO $HIMS $TERN
$SLS - pardon me @Maxamillion5000, i know some are just getting to know...
and for anyone interested in MONEY.
https://www.reddit.com/r/sellasLifescience/search/?q=aml-mr&cId=057d1aab-2b7d-4bf0-a2d4-c3227af101f8&iId=8d5110f2-0189-40ea-bc04-b363b5cad724 - link for 009 DD.
SLS009 is the only Effective Agent for the Most Dire AML Prognosis, AML-MR - Mutations TP53 Asxl1 Runx Ezh2 -- AML that is mutated, often after Chemo from other cancers.
SLS009 has direct market Comps $TERN $FTSV both bought for $5B+ based on Lesser PH2B DATA SLS009 Published at ASH.
